US 11718679
CD137 antibodies and PD-1 antagonists and uses thereof
granted A61KA61K2039/507A61K39/001111
Quick answer
US patent 11718679 (CD137 antibodies and PD-1 antagonists and uses thereof) held by Compass Therapeutics LLC expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/507, A61K39/001111, A61K39/001117, A61P